A detailed history of Focus Financial Network, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Focus Financial Network, Inc. holds 17,457 shares of ABBV stock, worth $3.39 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
17,457
Previous 16,113 8.34%
Holding current value
$3.39 Million
Previous $2.65 Billion 15.32%
% of portfolio
0.13%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $208,037 - $242,941
1,344 Added 8.34%
17,457 $3.06 Billion
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $2.58 Million - $2.93 Million
16,113 New
16,113 $2.65 Billion
Q3 2023

Jul 22, 2024

SELL
$133.59 - $154.65 $161,643 - $187,126
-1,210 Reduced 7.53%
14,866 $2.22 Billion
Q2 2023

Jul 22, 2024

SELL
$132.51 - $164.9 $44,390 - $55,241
-335 Reduced 2.04%
16,076 $2.17 Billion
Q1 2023

Jul 22, 2024

SELL
$144.61 - $166.54 $151,262 - $174,200
-1,046 Reduced 5.99%
16,411 $2.62 Billion
Q4 2022

Jul 24, 2024

BUY
$138.31 - $165.87 $977,990 - $1.17 Million
7,071 Added 70.0%
17,173 $2.78 Billion
Q3 2022

Jul 24, 2024

BUY
$134.21 - $153.93 $3,221 - $3,694
24 Added 0.14%
17,093 $2.29 Billion
Q2 2022

Jul 24, 2024

BUY
$137.62 - $174.96 $41,148 - $52,313
299 Added 1.78%
17,069 $2.61 Billion
Q1 2022

Jul 24, 2024

SELL
$131.98 - $163.75 $4.5 Million - $5.58 Million
-34,097 Reduced 67.03%
16,770 $2.72 Billion
Q4 2021

Jul 24, 2024

BUY
$107.43 - $135.93 $298,977 - $378,293
2,783 Added 5.79%
50,867 $6.89 Billion
Q3 2021

Jul 24, 2024

BUY
$106.4 - $120.78 $262,488 - $297,964
2,467 Added 5.41%
48,084 $5.19 Billion
Q2 2021

Jul 24, 2024

SELL
$105.21 - $117.21 $1.5 Million - $1.67 Million
-14,217 Reduced 23.76%
45,617 $5.14 Billion
Q1 2021

Jul 24, 2024

BUY
$102.3 - $112.62 $4.5 Million - $4.96 Million
44,020 Added 278.36%
59,834 $6.48 Billion
Q4 2020

Jul 24, 2024

BUY
$80.49 - $108.67 $108,098 - $145,943
1,343 Added 9.28%
15,814 $1.69 Billion
Q3 2020

Jul 24, 2024

BUY
$85.91 - $100.83 $45,875 - $53,843
534 Added 3.83%
14,471 $1.27 Billion
Q2 2020

Jul 24, 2024

BUY
$73.37 - $98.18 $412,412 - $551,869
5,621 Added 67.59%
13,937 $1.37 Billion
Q1 2020

Jul 24, 2024

SELL
$64.5 - $97.79 $589,594 - $893,898
-9,141 Reduced 52.36%
8,316 $634 Million
Q4 2019

Jul 24, 2024

BUY
$72.13 - $90.25 $214,731 - $268,674
2,977 Added 41.78%
10,102 $894 Million
Q3 2019

Jul 24, 2024

SELL
$62.98 - $75.72 $9,887 - $11,888
-157 Reduced 2.16%
7,125 $539 Million
Q2 2019

Jul 24, 2024

BUY
$65.7 - $83.98 $10,577 - $13,520
161 Added 2.26%
7,282 $530 Million
Q1 2019

Jul 24, 2024

SELL
$77.14 - $90.79 $797,319 - $938,405
-10,336 Reduced 59.21%
7,121 $574 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Focus Financial Network, Inc. Portfolio

Follow Focus Financial Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focus Financial Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Focus Financial Network, Inc. with notifications on news.